Xgeva and Disease recurrence - a phase IV clinical study of FDA data

Summary:

Disease recurrence is reported as a side effect among people who take Xgeva (denosumab), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Ibrance, and have Breast cancer female.

The phase IV clinical study analyzes which people have Disease recurrence when taking Xgeva. It is created by eHealthMe based on reports of 37,636 people who have side effects when taking Xgeva from the FDA, and is updated regularly.

What is Xgeva?

Xgeva has active ingredients of denosumab. It is often used in breast cancer. eHealthMe is studying from 37,717 Xgeva users. Check the latest studies of Xgeva.

What is Disease recurrence?

Disease recurrence is found to be associated with 1,243 drugs and 1,550 conditions by eHealthMe. Check the latest studies of Disease recurrence.

On Jul, 06, 2026

37,636 people reported to have side effects when taking Xgeva.
Among them, 29 people (0.08%) have Disease recurrence.

Among these 29 people:

How long have people been on Xgeva when they have Disease recurrence? *

What is the gender of people who have Disease recurrence when taking Xgeva? *

female: 84.62 %
male: 15.38 %

What is the age of people who have Disease recurrence when taking Xgeva? *

What are other drugs people take besides Xgeva? *

Ibrance: 9 people, 31.03%
Faslodex: 8 people, 27.59%
Zyrtec: 7 people, 24.14%
Vitamin D3: 7 people, 24.14%
Aspirin: 6 people, 20.69%
Magnesium: 6 people, 20.69%
Biotin: 6 people, 20.69%
Tykerb: 6 people, 20.69%
Calcium: 5 people, 17.24%
Flonase Sensimist Allergy Relief: 5 people, 17.24%

What are other side effects people have besides Disease recurrence? *

White Blood Cell Count Decreased: 9 people, 31.03%
Weakness: 9 people, 31.03%
Back Pain: 8 people, 27.59%
Rashes (redness): 8 people, 27.59%
Fatigue (feeling of tiredness): 7 people, 24.14%
Neoplasm Progression (growth of tumour): 7 people, 24.14%
Nausea And Vomiting: 7 people, 24.14%
Dizziness: 6 people, 20.69%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 20.69%
Nausea (feeling of having an urge to vomit): 5 people, 17.24%

What are the existing conditions these people have? *

Breast Cancer Female: 7 people, 24.14%
Breast Cancer Metastatic: 5 people, 17.24%
Anaemia (lack of blood): 2 people, 6.90%
Cellulitis (infection under the skin): 2 people, 6.90%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 2 people, 6.90%
Bone Disorder: 2 people, 6.90%
Bone Giant Cell Tumor: 2 people, 6.90%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.45%
Breast Cancer Stage Iv: 1 person, 3.45%
Renal Cell Carcinoma (a kidney cancer): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Xgeva and have Disease recurrence?

- Check whether Disease recurrence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Xgeva:

Xgeva (37,717 reports)

Browse all side effects of Xgeva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Disease recurrence:

Disease recurrence (1,243 drugs)

Browse all the conditions that are associated with Disease recurrence:

Disease recurrence (1,550 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on denosumab (the active ingredients of Xgeva) and Xgeva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.